Gene Editing Emerges From the Lab
(Veteran tech columnist Jon Markman publishes Strategic Advantage, a guide to investing in the great digital transformation of business and society. Click here for a two-week trial.)
Editas ( (EDIT) – Get Report), CRISPR Therapeutics ( (CRSP) – Get Report) and Intellia Therapeutics